Look for your next weekly newsletter in your inbox.
The Future of Vaccine Equity and India’s Global Health Leadership
Better health begins with ideas
Editors' Note
Had COVID-19 vaccines been more equally distributed, an estimated 1.3 million people could have been alive today. That's the leading takeaway from a Think Global Health miniseries about the future of vaccine manufacturing—guest edited this week by award-winning journalist and former CFR press fellow Amy Maxmen.
The series rounds off with Prashant Yadav, academic director of the INSEAD Africa Initiative. He sketches the history behind India's rise as a global vaccine manufacturer, noting the crucial steps after the country gained independence in 1947 that motivated domestic drug manufacturing and ultimately reduced pharmaceutical costs.
Keeping the focus on India, Animesh Roul, executive director of the Society for the Study of Peace and Conflict in New Delhi, provides our recommended feature of the week. He explains how the country's Hindu philosophy of Vasudhaiva Kutumbakam (the world as one family) is setting up India to become a global health leader.
Until next week!—Nsikan Akpan, Managing Editor, and Caroline Kantis, Associate Editor